- Home
- SYBT vs RXRX Comparison
SYBT vs RXRX Comparison
Compare SYBT & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBT
- RXRX
- Stock Information
- Founded
- SYBT 1904
- RXRX 2013
- Country
- SYBT United States
- RXRX United States
- Employees
- SYBT N/A
- RXRX N/A
- Industry
- SYBT Major Banks
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- SYBT Finance
- RXRX Health Care
- Exchange
- SYBT Nasdaq
- RXRX Nasdaq
- Market Cap
- SYBT 2.2B
- RXRX 2.0B
- IPO Year
- SYBT N/A
- RXRX 2021
- Fundamental
- Price
- SYBT $73.25
- RXRX $6.18
- Analyst Decision
- SYBT Hold
- RXRX Buy
- Analyst Count
- SYBT 4
- RXRX 6
- Target Price
- SYBT $65.25
- RXRX $9.40
- AVG Volume (30 Days)
- SYBT 201.0K
- RXRX 5.5M
- Earning Date
- SYBT 10-23-2024
- RXRX 11-06-2024
- Dividend Yield
- SYBT 1.69%
- RXRX N/A
- EPS Growth
- SYBT N/A
- RXRX N/A
- EPS
- SYBT 3.63
- RXRX N/A
- Revenue
- SYBT $331,807,000.00
- RXRX $65,184,000.00
- Revenue This Year
- SYBT N/A
- RXRX $50.69
- Revenue Next Year
- SYBT $7.24
- RXRX $40.10
- P/E Ratio
- SYBT $20.18
- RXRX N/A
- Revenue Growth
- SYBT 1.02
- RXRX 37.64
- 52 Week Low
- SYBT $42.35
- RXRX $5.89
- 52 Week High
- SYBT $77.82
- RXRX $15.74
- Technical
- Relative Strength Index (RSI)
- SYBT 61.71
- RXRX 41.15
- Support Level
- SYBT $71.87
- RXRX $6.68
- Resistance Level
- SYBT $77.82
- RXRX $8.49
- Average True Range (ATR)
- SYBT 2.33
- RXRX 0.51
- MACD
- SYBT 0.47
- RXRX -0.02
- Stochastic Oscillator
- SYBT 68.48
- RXRX 1.07
About SYBT Stock Yards Bancorp Inc.
Stock Yards Bancorp Inc operates as a bank. The bank has two reportable operating segments namely Commercial Banking and Wealth Management and trust. Its services include loan and deposit services, cash management services, securities brokerage activities, mortgage origination, and others. It generates a majority of its revenue from the Commercial Banking segment.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.